Table1_Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer.XLSX
收藏frontiersin.figshare.com2023-06-02 更新2025-01-16 收录
下载链接:
https://frontiersin.figshare.com/articles/dataset/Table1_Integrated_high-throughput_analysis_identifies_super_enhancers_in_metastatic_castration-resistant_prostate_cancer_XLSX/23119937/1
下载链接
链接失效反馈官方服务:
资源简介:
Background: Metastatic castration-resistant prostate cancer (mCRPC) is a highly aggressive stage of prostate cancer, and non-mutational epigenetic reprogramming plays a critical role in its progression. Super enhancers (SE), epigenetic elements, are involved in multiple tumor-promoting signaling pathways. However, the SE-mediated mechanism in mCRPC remains unclear.Methods: SE-associated genes and transcription factors were identified from a cell line (C4-2B) of mCRPC by the CUT&Tag assay. Differentially expressed genes (DEGs) between mCRPC and primary prostate cancer (PCa) samples in the GSE35988 dataset were identified. What’s more, a recurrence risk prediction model was constructed based on the overlapping genes (termed SE-associated DEGs). To confirm the key SE-associated DEGs, BET inhibitor JQ1 was applied to cells to block SE-mediated transcription. Finally, single-cell analysis was performed to visualize cell subpopulations expressing the key SE-associated DEGs.Results: Nine human TFs, 867 SE-associated genes and 5417 DEGs were identified. 142 overlapping SE-associated DEGs showed excellent performance in recurrence prediction. Time-dependent receiver operating characteristic (ROC) curve analysis showed strong predictive power at 1 year (0.80), 3 years (0.85), and 5 years (0.88). The efficacy of his performance has also been validated in external datasets. In addition, FKBP5 activity was significantly inhibited by JQ1.Conclusion: We present a landscape of SE and their associated genes in mCPRC, and discuss the potential clinical implications of these findings in terms of their translation to the clinic.
背景:转移性去势抵抗性前列腺癌(mCRPC)是前列腺癌的高度侵袭性阶段,非突变表观遗传重编程在其进展中扮演着至关重要的角色。超级增强子(SE),作为一种表观遗传元件,参与多种肿瘤促进信号通路。然而,mCRPC中SE介导的机制尚不明确。方法:通过CUT&Tag检测法从mCRPC细胞系(C4-2B)中鉴定了SE相关的基因和转录因子。在GSE35988数据集中,鉴定了mCRPC与原发前列腺癌(PCa)样本之间的差异表达基因(DEGs)。此外,基于重叠基因(称为SE相关DEGs)构建了复发风险预测模型。为了验证关键SE相关DEGs,对细胞施加了BET抑制剂JQ1以阻断SE介导的转录。最终,通过单细胞分析来可视化表达关键SE相关DEGs的细胞亚群。结果:鉴定出九种人类转录因子、867个SE相关基因和5417个DEGs。142个重叠的SE相关DEGs在复发预测中表现出优异的性能。时间依赖性受试者工作特征(ROC)曲线分析显示,在1年(0.80)、3年(0.85)和5年(0.88)时具有强大的预测能力。其效能亦已在外部数据集中得到验证。此外,FKBP5活性被JQ1显著抑制。结论:本研究呈现了mCRPC中SE及其相关基因的图谱,并探讨了这些发现的临床转化潜力,以及其在临床应用中的潜在意义。
提供机构:
Frontiers



